CCNG2 and triple-negative breast carcinoma: The gene expression levels of CCNG2 in triple-negative breast cancers (n = 51) were significantly lower (p <0.001; fold change 1.9) than those in normal breast tissues (n = 25) in the microarray data (Additional file 5).